22 дек. 2023 г. · We saw the most visited journal scan content on ACC.org focusing on myocardial infarction, heart failure, atrial fibrillation, as well as prevention.

9 февр. 2024 г. · In 2023, there were several large landmark cardiology trials, including DELIVER, LODESTAR, SELECT, CLEAR Outcomes, and ARTESIA.

14 мая 2024 г. · In 2023, several landmark trials with the potential to change clinical practice were presented at major international meetings including the ...

We discuss the most recent evidence on intra-vascular imaging, newer advances in heart failure, atrial fibrillation and conclude with a brief overview of trials ...

14 мая 2024 г. · This article presents a summary of key clinical cardiology trials published and presented during the past year and should be of interest to both practising ...

15 дек. 2023 г. · The Top Cardiology Trials of 2023 · Bempedoic Acid and Statin Intolerance · Oral PCSK9 Inhibitor and Gene Editing · Acoramidis and ATTR ...

22 окт. 2024 г. · This article presents a summary of key clinical cardiology trials published and presented during the past year and should be of interest to both practising ...

7 июн. 2023 г. · We picked up 5 trials that impacted our practice: CLEAR OUTCOMES trial, REVIVED BCIS2 trial, DELIVER trial, ADVOR trial, and EBC MAIN trial.

Take an in-depth look at some of the featured Late Breaking Clinical Trials from the American College of Cardiology's #ACC23 in New Orleans, Louisiana.

This page features full coverage of the latest science from ACC.23/WCC, including trial summaries, news stories, journal scans, slides, videos and more.